Lexeo Therapeutics, Inc.
LXEO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001907108
In the last 90 days, Lexeo Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $410.9M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Lexeo Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 69
- +10 vs. Q2 2024
- Shares held
- 29.7M
- +3.95M (+15.3%) vs. Q2 2024
- Total value
- $268.8M
- −$144.8M (−35.0%) vs. Q2 2024
- New holders
- 16
- 36 more added
- Sold out
- 6
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 141 | $410.9M |
| Q1 2026 | 139 | $458.7M |
| Q4 2025 | 146 | $759.2M |
| Q3 2025 | 109 | $327.5M |
| Q2 2025 | 90 | $169.9M |
| Q1 2025 | 88 | $100.0M |
| Q4 2024 | 90 | $194.2M |
| Q3 2024 | 69 | $268.8M |
| Q2 2024 | 60 | $426.3M |
| Q1 2024 | 54 | $361.5M |
| Q4 2023 | 31 | $217.1M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Lexeo Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 3,763,195 | $34.0M | 0.02% | +599,203+18.9% | Added |
| Citadel Advisors LLC | 2,723,363 | $24.6M | 0.03% | +164,752+6.4% | Added |
| Adage Capital Partners GP, L.L.C. | 2,597,736 | $23.5M | 0.04% | 00.0% | Unchanged |
| D1 Capital Partners L.P.SuperinvestorD1 Capital Partners | 2,506,607 | $22.7M | 0.44% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 2,355,904 | $21.3M | 13.31% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 1,855,986 | $16.8M | 0.29% | −1,513,161−44.9% | Reduced |
| BlackRock, Inc. | 1,630,287 | $14.7M | 0.00% | +1,630,287 | New |
| Frazier Life Sciences Management, L.P. | 1,250,786 | $11.3M | 0.45% | +1,250,786 | New |
| Blackstone Group Inc. | 1,158,617 | $10.5M | 0.05% | +352,860+43.8% | Added |
| Novo Holdings A/S | 1,122,581 | $10.1M | 0.50% | −327,919−22.6% | Reduced |
| Vanguard Group Inc | 864,711 | $7.82M | 0.00% | +234,792+37.3% | Added |
| Woodline Partners LP | 851,961 | $7.70M | 0.07% | +27,887+3.4% | Added |
| Vestal Point Capital, LP | 850,000 | $7.68M | 0.61% | +10,000+1.2% | Added |
| Verition Fund Management LLC | 777,320 | $7.03M | 0.05% | +355,928+84.5% | Added |
| Braidwell LP | 728,777 | $6.59M | 0.19% | −653,704−47.3% | Reduced |
| Siren, L.L.C. | 603,435 | $5.46M | 0.27% | +603,435 | New |
| Geode Capital Management, LLC | 553,247 | $5.00M | 0.00% | +256,635+86.5% | Added |
| Ra Capital Management, L.P. | 546,554 | $4.94M | 0.06% | −126,158−18.8% | Reduced |
| Point72 Asset Management, L.P. | 370,407 | $3.35M | 0.01% | +370,407 | New |
| Laurion Capital Management LP | 260,228 | $2.35M | 0.15% | −193,354−42.6% | Reduced |
| Ikarian Capital, LLC | 257,216 | $2.33M | 0.72% | +257,216 | New |
| State Street Corp | 253,946 | $2.30M | 0.00% | +57,674+29.4% | Added |
| DAFNA Capital Management LLC | 250,583 | $2.27M | 0.54% | +250,583 | New |
| Morgan Stanley | 241,828 | $2.19M | 0.00% | +229,165+1,809.7% | Added |
| Northern Trust Corp | 200,099 | $1.81M | 0.00% | +105,192+110.8% | Added |
| Perceptive Advisors LLC | 139,835 | $1.26M | 0.03% | +139,835 | New |
| Boothbay Fund Management, LLC | 107,484 | $971.7K | 0.03% | +107,484 | New |
| Exome Asset Management LLC | 88,148 | $796.9K | 0.54% | +88,148 | New |
| Goldman Sachs Group Inc | 76,751 | $693.8K | 0.00% | +49,898+185.8% | Added |
| Charles Schwab Investment Management Inc | 63,874 | $577.4K | 0.00% | +33,013+107.0% | Added |
| Polar Asset Management Partners Inc. | 59,800 | $540.6K | 0.01% | −5,500−8.4% | Reduced |
| ADAR1 Capital Management, LLC | 57,166 | $516.8K | 0.09% | +55,866+4,297.4% | Added |
| Wellington Management Group LLP | 51,892 | $469.1K | 0.00% | +29,791+134.8% | Added |
| Barclays PLC | 50,210 | $453.9K | 0.00% | +31,057+162.2% | Added |
| Bank of New York Mellon Corp | 47,983 | $433.8K | 0.00% | +16,177+50.9% | Added |
| Bank of America Corp | 38,785 | $350.6K | 0.00% | +24,134+164.7% | Added |
| Millennium Management LLC | 37,114 | $335.5K | 0.00% | −352−0.9% | Reduced |
| Nuveen Asset Management, LLC | 36,050 | $325.9K | 0.00% | +17,757+97.1% | Added |
| Jane Street Group, LLC | 35,677 | $322.5K | 0.00% | +8,918+33.3% | Added |
| Prelude Capital Management, LLC | 30,725 | $277.8K | 0.02% | +30,725 | New |
| Jacobs Levy Equity Management, Inc | 30,346 | $274.3K | 0.00% | +30,346 | New |
| PDT Partners, LLC | 26,608 | $240.5K | 0.02% | +26,608 | New |
| Citigroup Inc | 23,105 | $208.9K | 0.00% | +11,560+100.1% | Added |
| Rhumbline Advisers | 21,070 | $190.5K | 0.00% | +7,713+57.7% | Added |
| Caxton Corp | 17,851 | $161.4K | 0.67% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 15,970 | $144.4K | 0.00% | +5,220+48.6% | Added |
| MetLife Investment Management | 14,223 | $128.6K | 0.00% | +7,803+121.5% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 12,869 | $116.3K | 0.00% | +7,988+163.7% | Added |
| Corebridge Financial, Inc. | 12,600 | $113.9K | 0.00% | +7,093+128.8% | Added |
| UBS Group AG | 11,112 | $100.5K | 0.00% | +7,983+255.1% | Added |
| JPMorgan Chase & Co | 10,278 | $92.9K | 0.00% | +5,915+135.6% | Added |
| Values First Advisors, Inc. | 7,446 | $67.3K | 0.04% | +7,446 | New |
| Wells Fargo & Company | 7,442 | $67.3K | 0.00% | +4,101+122.7% | Added |
| BNP Paribas Arbitrage, SA | 5,541 | $50.1K | 0.00% | +3,591+184.2% | Added |
| Deutsche Bank AG | 4,848 | $43.8K | 0.00% | +288+6.3% | Added |
| New York State Common Retirement Fund | 4,187 | $37.9K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,153 | $28.0K | 0.00% | +2,186+226.1% | Added |
| Legal & General Group Plc | 2,527 | $22.8K | 0.00% | +1,517+150.2% | Added |
| Ameritas Investment Partners, Inc. | 2,387 | $21.6K | 0.00% | +1,364+133.3% | Added |
| California State Teachers Retirement System | 1,735 | $15.7K | 0.00% | +993+133.8% | Added |
| Tower Research Capital LLC (TRC) | 1,417 | $12.8K | 0.00% | −158−10.0% | Reduced |
| Amalgamated Bank | 623 | $6.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 595 | $5.38K | 0.00% | +460+340.7% | Added |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 174 | $1.57K | 0.00% | +174 | New |
| Steward Partners Investment Advisory, LLC | 100 | $904 | 0.00% | +100 | New |
| Sterling Capital Management LLC | 27 | $244 | 0.00% | +27 | New |
| SRS Capital Advisors, Inc. | 12 | $109 | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 33 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 10 | $0 | 0.00% | −6−37.5% | Reduced |
| Artal Group S.A. | 0 | $0 | 0.00% | −603,435−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −132,187−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −14,035−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −10,542−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |